These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20863340)

  • 21. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roundtable discussion. Investigational exclusion, clinical trials, and cancer.
    Goodman C
    Oncology (Williston Park); 1998 Nov; 12(11A):37-49. PubMed ID: 10028502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Good clinical practices in therapeutic trials in geriatrics especially in Alzheimer type senile dementia].
    Piette F
    Therapie; 1991; 46(1):83-7. PubMed ID: 2020932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scales as outcome measures for Alzheimer's disease.
    Black R; Greenberg B; Ryan JM; Posner H; Seeburger J; Amatniek J; Resnick M; Mohs R; Miller DS; Saumier D; Carrillo MC; Stern Y
    Alzheimers Dement; 2009 Jul; 5(4):324-39. PubMed ID: 19560103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary care professionals' perceptions of depression in older people: a qualitative study.
    Murray J; Banerjee S; Byng R; Tylee A; Bhugra D; Macdonald A
    Soc Sci Med; 2006 Sep; 63(5):1363-73. PubMed ID: 16698157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Older people are wrongly excluded from drug trials.
    Rehwagen C
    BMJ; 2005 Dec; 331(7529):1360. PubMed ID: 16339243
    [No Abstract]   [Full Text] [Related]  

  • 27. European Cancer Organisation backs proposals to revise EU Clinical Trials Directive.
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):301-3. PubMed ID: 20214510
    [No Abstract]   [Full Text] [Related]  

  • 28. Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region.
    Michel JP; Chidiac C; Grubeck-Loebenstein B; Johnson RW; Lambert PH; Maggi S; Moulias R; Nicholson K; Werner H
    Rejuvenation Res; 2009 Apr; 12(2):127-35. PubMed ID: 19415978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New regulatory rules for clinical trials in the United States and the European Union: key points and comparisons.
    Miossec M; Miossec P
    Arthritis Rheum; 2006 Dec; 54(12):3735-40. PubMed ID: 17133535
    [No Abstract]   [Full Text] [Related]  

  • 30. Ethical considerations related to the inclusion of women in clinical trials.
    Fullerton JT; Sadler GR
    J Midwifery Womens Health; 2004; 49(3):194-202. PubMed ID: 15134672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Older women's health. Task Force on Older Women's Health. American Geriatrics Society.
    J Am Geriatr Soc; 1993 Jun; 41(6):680-3. PubMed ID: 8505468
    [No Abstract]   [Full Text] [Related]  

  • 32. Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation.
    Martin PJ; Antin JH; Weisdorf DJ; Paton V; Horowitz MM
    Biol Blood Marrow Transplant; 2002; 8(6):295-302. PubMed ID: 12108915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A challenge: The American Geriatric Society needs to address the lack of inclusion of older adults in new drug evaluation.
    Slattum PW; Schwartz JB
    J Am Geriatr Soc; 2021 Sep; 69(9):2684-2688. PubMed ID: 34062612
    [No Abstract]   [Full Text] [Related]  

  • 34. [The exclusion of older patients from clinical trials regarding heart failure. Causes and consequences].
    Cherubini A; Cerenzia A; Zengarini E
    Recenti Prog Med; 2012 Mar; 103(3):103-8. PubMed ID: 22430821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy.
    Cerreta F; Eichler HG; Rasi G
    N Engl J Med; 2012 Nov; 367(21):1972-4. PubMed ID: 23171092
    [No Abstract]   [Full Text] [Related]  

  • 36. Aging, the Medical Subspecialties, and Career Development: Where We Were, Where We Are Going.
    Hurria A; High KP; Mody L; McFarland Horne F; Escobedo M; Halter J; Hazzard W; Schmader K; Klepin H; Lee S; Makris UE; Rich MW; Rogers S; Wiggins J; Watman R; Choi J; Lundebjerg N; Zieman S
    J Am Geriatr Soc; 2017 Apr; 65(4):680-687. PubMed ID: 28092400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AGS Report on Engagement Related to the NIH Inclusion Across the Lifespan Policy.
    Vaughan CP; Dale W; Allore HG; Binder EF; Boyd CM; Bynum JPW; Gurwitz JH; Lundebjerg NE; Trucil DE; Supiano MA; Colón-Emeric C
    J Am Geriatr Soc; 2019 Feb; 67(2):211-217. PubMed ID: 30693956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial design for older people--time for a rethink.
    Witham MD; George J
    QJM; 2014 Jan; 107(1):15-6. PubMed ID: 24003240
    [No Abstract]   [Full Text] [Related]  

  • 39. Conducting and reporting trials for older people.
    Witham MD; Stott DJ
    Age Ageing; 2017 Nov; 46(6):889-894. PubMed ID: 28985243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.
    Hurria A; Levit LA; Dale W; Mohile SG; Muss HB; Fehrenbacher L; Magnuson A; Lichtman SM; Bruinooge SS; Soto-Perez-de-Celis E; Tew WP; Postow MA; Cohen HJ;
    J Clin Oncol; 2015 Nov; 33(32):3826-33. PubMed ID: 26195697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.